In the last trading session, 1.34 million Caredx Inc (NASDAQ:CDNA) shares changed hands as the company’s beta touched 1.85. With the company’s per share price at $22.05 changed hands at -$3.02 or -12.05% during last session, the market valuation stood at $1.18B. CDNA’s last price was a discount, traded about -58.0% off its 52-week high of $34.84. The share price had its 52-week low at $7.42, which suggests the last value was 66.35% up since then. When we look at Caredx Inc’s average trading volume, we note the 10-day average is 0.76 million shares, with the 3-month average coming to 813.91K.
Analysts gave the Caredx Inc (CDNA) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.11. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended CDNA as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight. Caredx Inc’s EPS for the current quarter is expected to be 0.07.
Caredx Inc (NASDAQ:CDNA) trade information
Instantly CDNA was in red as seen at the end of in last trading. With action -5.53%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 2.99%, with the 5-day performance at -5.53% in the red. However, in the 30-day time frame, Caredx Inc (NASDAQ:CDNA) is -8.81% down. Looking at the short shares, we see there were 3.97 million shares sold at short interest cover period of 5.6 days.
The consensus price target for the stock as assigned by Wall Street analysts is 37.5, meaning bulls need an upside of 41.2% from its current market value. According to analyst projections, CDNA’s forecast low is 35 with 40 as the target high. To hit the forecast high, the stock’s price needs a -81.41% plunge from its current level, while the stock would need to soar -58.73% for it to hit the projected low.
Caredx Inc (CDNA) estimates and forecasts
Data shows that the Caredx Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 36.62% over the past 6 months, a 167.19% in annual growth rate that is considerably higher than the industry average of 5.10%. Year-over-year growth is forecast to reach 18.20% up from the last financial year.
Consensus estimates given by 3 financial analysts project the company’s revenue in the current quarter to hit an average of 83.5M. 3 analysts are of the opinion that Caredx Inc’s revenue for the current quarter will be 86.72M. The company’s revenue for the corresponding quarters a year ago was 65.57M and 72.05M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 27.35%. The estimates for the next quarter sales put growth at 20.36%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -21.96%. The 2025 estimates are for Caredx Inc earnings to increase by 78.34%.
CDNA Dividends
Caredx Inc is expected to release its next quarterly earnings report in February.
Caredx Inc (NASDAQ:CDNA)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 3.45% of Caredx Inc shares while 96.59% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 100.04%. There are 96.59% institutions holding the Caredx Inc stock share, with ARK INVESTMENT MANAGEMENT LLC the top institutional holder. As of 2024-06-30, the company held 10.925% of the shares, roughly 5.7 million CDNA shares worth $88.56 million.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 10.1283% or 5.29 million shares worth $82.1 million as of 2024-06-30.
Among Mutual Funds, the top two as of Nov 30, 2024 were ARK ETF Tr-ARK Genomic Revolution ETF and Vanguard Total Stock Market Index Fund . With 2.59 shares estimated at $57.06 million under it, the former controlled 4.82% of total outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held about 2.83% of the shares, roughly 1.52 shares worth around $33.46 million.
